The Swiss Glucose Variability Study

Phase 4

• Conditions: Type 2 Diabetes

• Registration Number: NCT01426737
• Lead Sponsor: University of Zurich

Brief Summary

The purpose of this study is to explore long term glucose variability of a combination therapy of metformin and vildagliptin compared to a metformin - gliclazide combination.

Multicenter, randomized, open, parallel group, Phase IV study, of 18 months duration.

* Trial with medicinal product

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04
• Study First Submitted: 2011-04-18
• Status Verified: 2011-08
• Study First Submitted QC: 2011-08-29
• Last Update Submitted: 2011-08-29
• Study First Posted: 2011-08-31
• Last Update Posted: 2011-08-31
• Primary Completion: 2013-01
• Study Completion: 2013-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Mean amplitude of glycemic excursion as described by Service et al. (1970) calculated from the glucose excursions of the CGMS profiles using MiniMedSolution Software (MedtronicMiniMed).	48h

Trial Locations

Locations (1)

Universitiy Hospital; 🇨🇭 Zurich, Switzerland